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International Randomized Clinical 
Trial, Stroke Inpatient Rehabilitation 
With Reinforcement of Walking Speed 
(SIRROWS), Improves Outcomes
Bruce H. Dobkin, MD,1 Prudence Plummer-D’Amato, PhD,2
Robert Elashoff, PhD,1 Jihey Lee, PhD1, and the SIRROWS Group
Abstract
Background. Feedback about performance may optimize motor relearning after stroke. Objectives. Develop an international 
collaboration to rapidly test the potential efficacy of daily verbal feedback about walking speed during inpatient rehabilitation 
after stroke, using a protocol that requires no research funds. Methods. This phase 2, single-blinded, multicenter trial 
randomized inpatients to either feedback about self-selected fast walking speed (daily reinforcement of speed, DRS) 
immediately after a single, daily 10-m walk or to no reinforcement of speed (NRS) after the walk, performed within the 
context of routine physical therapy. The primary outcome was velocity for a 15.2-m (50-foot) timed walk at discharge. 
Secondary outcomes were walking distance in 3 minutes, length of stay (LOS), and level of independence (Functional 
Ambulation Classification, FAC). Results. Within 18 months, 179 participants were randomized. The groups were balanced 
for age, gender, time from onset of stroke to entry, initial velocity, and level of walking-related disability. The walking 
speed at discharge for DRS (0.91 m/s) was greater (P = .01) than that for NRS (0.72 m/s). No difference was found for 
LOS. LOS for both DRS and NRS was significantly shorter, however, for those who had mean walking speeds >0.4 m/s 
at entry. The DRS group did not have a higher proportion of FAC independent walkers (P = .1) and did not walk longer 
distances (P = .09). Conclusions. An Internet-based collaboration of 18 centers found that feedback about performance 
once a day produced gains in walking speed large enough to permit unlimited, slow community ambulation at discharge 
from inpatient rehabilitation.
Keywords
stroke rehabilitation, feedback, walking speed, randomized clinical trial, Functional Ambulation Classification
Introduction
Most recent clinical trials of walking interventions for 
neuro rehabilitation use walking speed as a primary outcome 
measure and include walking distance over 2 to 6 minutes 
and level of independence in gait as secondary outcomes.1-5 
Speed is a continuous measurement with high reliability and 
responsiveness.6 Speed also affects energy use and reflects 
overall locomotor-related ability.7,8 For example, 3 months 
after stroke, a velocity of 0.8 m/s during a short distance 
walk correlated with slow unrestricted community ambula-
tion, limited community mobility if more than 0.4 m/s, and 
unrestricted home mobility if it was from 0.26 to 0.4 m/s.9 
An increase in gait velocity that produces a transition to a 
higher level of ambulation results in better function and 
quality of life, based on the Stroke Impact Scale, especially 
for household ambulators.10 Thus, aiming to maximize 
walking speed during inpatient and outpatient rehabilitation 
ought to be a therapeutic goal. Few trials, however, have 
attempted and shown the benefit of practice at higher train-
ing speeds, and these used treadmill training.11,12
Many reviews discuss the need for intensive, task-related 
practice after stroke that is goal oriented and supported by 
schedules of feedback about performance.13-15 The value of 
structured verbal feedback to improve walking speed during 
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inpatient rehabilitation after stroke, however, has not been 
tested. To examine the potential for summary feedback about 
performance as a therapeutic adjunct, we organized the Stroke 
Inpatient Rehabilitation With Reinforcement of Walking 
Speed (SIRROWS) multicenter, randomized clinical trial 
(MRCT).
A second objective was to determine the feasibility of 
uniting clinicians in an international network to conduct the 
RCT, so as to improve the rate of recruitment and obtain 
more generalizable results. Simplicity of the research design 
was imperative because we had no research funding to offer 
centers and wanted to include willing sites even if they did 
not have extensive clinical trial experience. These poten-
tial limitations suggested that we should conduct the trial 
within the usual activities of each inpatient center. SIRROWS 
then, tested the hypothesis that feedback about walking 
speed once a day, compared with no feedback, would lead to 
faster walking at discharge from inpatient stroke rehabilita-
tion and, in turn, possibly shorten the length of the inpatient 
rehabilitation stay.
Methods
An open invitation to join the clinical trials network was 
e-mailed to all members of the World Federation for 
NeuroRehabilitation and the American Society of Neuro-
Rehabilitation and advertised at national meetings and in 
a journal in 2006. The coordinating center at the University 
of California Los Angeles (UCLA) received expressions of 
interest from 47 sites that had inpatient rehabilitation services: 
14 within the United States and 33 from 22 other countries. 
Eight American sites obtained institutional review board 
(IRB) approval and entered participants. Several others 
said they could not participate because of high IRB fees 
charged by their institutions. Also, 14 sites outside the 
United States obtained IRB approval, and 10 entered par-
ticipants. Several others were not eligible because they did 
not have a human subjects protection system. The UCLA 
study center engaged the site investigators by Email to 
manage instructions and questions as well as through the 
study Web site and a quarterly electronic newsletter.
Subjects
Patients admitted to an inpatient facility because they qual-
ified for stroke rehabilitation were eligible if they were at 
least 35 years of age with unilateral hemiparesis (strength 
on the British Medical Council Scale ≤ 4/5 at the ankle, 
knee, and hip). Participants had to be able to follow simple 
instructions for reinforcement about walking speed and take 
at least 5 steps with no more than maximal assistance of 1 
person. Exclusion criteria included prior stroke with 
residual impairment and pain on stepping, dyspnea or 
angina on modest exertion, or other premorbid limitations 
on walking. Entry could be delayed after admission if a 
person satisfied all other selection criteria but was not yet 
able to take 5 steps or was experiencing a transient medi-
cal problem. In this case, a daily examination was 
performed, and the patient was randomized immediately 
after meeting criteria. Eligibility was determined by the 
treating physician-investigator during routine inpatient 
admission assessment. All participants had to sign an 
informed consent patterned after the one approved by the 
IRB at UCLA and tailored to each institution. The trial was 
registered at www.ClincialTrials.gov (NCT0042480).
Randomization
After obtaining informed consent, the site investigator entered 
the patient’s descriptor information into an online patient 
entry form. On submission, a computer-generated system 
provided immediate notification of the randomization result. 
Because of a software problem with the automatic system 
approximately half way through the trial, manual random-
ization was adopted, and investigators were notified within 
24 hours by e-mail of the result. Assignment was carried 
out by a random permuted block design with a block size 
of 4. Stratification by site was a prerandomization factor.
Interventions
All participants received the site’s conventional inpatient 
rehabilitation. They also performed a daily 10-m walk (or 
shorter distance walk until 10 m was feasible) as part of 
a physical therapy session. The experimental group received 
feedback about walking speed (daily reinforcement of 
speed, DRS) after each day’s 10-m walk. The DRS partici-
pants were timed after being told to walk as quickly as they 
felt was safe, and then, they were given specific feedback 
and encouragement concerning speed. For example, “Very 
good! You walked that in (number of) seconds.” Then, 
(a) “This is better by (number of) seconds” or (b) “This 
shows you are holding your own” or (c) “I believe that you 
will soon be able to walk a bit faster.” The control group 
was not timed during its daily 10-m walk and received no 
information about walking speed (no reinforcement of 
speed, NRS).
Measures
Baseline descriptors were time from onset of stroke, stroke 
type and general location (determined by radiological or 
clinical information), age, race, and gender. Stroke sever-
ity was assessed at baseline by the National Institutes of 
Health Stroke Scale (NIHSS), disability by the modified 
Rankin Scale (mRS), and whether human assistance was 
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needed to walk based on the Functional Ambulation Clas-
sification (FAC).16
The primary outcome measure, as well as an interim 
measurement, was self-selected walking speed (m/s) at dis-
charge, performed with instructions to walk as fast as the 
participant deemed to be safe over a flat, 15.2-m (50-foot) 
walkway. The distance was greater than the daily timed 
walk. Participants were given an extra 2 m (6 feet) at each 
end of the walkway to allow a steady pace to be achieved 
without acceleration at the start and deceleration at the end. 
The stopwatch started when the lead foot began to cross the 
start line and ended when the lead foot crossed the finish 
line. For patients who were unable to walk 15.2 m but could 
take 5 steps, the test was performed over a shorter, feasible 
distance, until a 15.2-m walk could be accomplished. The 
treating physical therapist could assist the participant as nec-
essary but did not provide any feedback or encouragement. 
The participant’s usual assistive and orthotic devices were 
permitted for all evaluations. Walking speed was assessed at 
study entry and at 2-week intervals during inpatient reha-
bilitation for up to a maximum of 8 weeks and at inpatient 
discharge. We encouraged follow-up evaluations at 3 and 6 
months after discharge. The FAC was also recorded with 
each walking test of velocity. The average of 2 trials of 
the 15.2-m walk was recorded at discharge and follow-up 
assessments. To minimize fatigue, only a single trial was 
performed at baseline and during inpatient rehabilitation.
Secondary outcomes were distance walked in 3 minutes 
at discharge and length of stay (LOS) for inpatient rehabili-
tation. The distance of the walkway for the 3-minute walk 
varied across sites according to available space, but most 
used a 30.5 m (100-foot) straight walkway and 180° turns. 
The distance traveled in meters was recorded as well as the 
number of rests. The test was carried out after 4 weeks of 
inpatient rehabilitation (if applicable), at discharge, and if 
feasible at 3 and 6 months postdischarge. The primary and 
secondary walking outcomes were measured by a blinded 
therapist who did not work on the inpatient unit and who 
performed the tests on all participants at her site. Because 
improvement of the level of independence for mobility is a 
major goal of inpatient rehabilitation, the walking speed at 
discharge was anticipated to affect the LOS.
Computer-Based Data Entry
A manual of operations was provided to each user. The study 
Web site familiarized the principal investigator and the 
blinded observer with procedures and data entry forms. The 
online database was created using a simple Wiki-based 
engine. The database was password protected. Each PI and 
blinded observer had different login codes to enter data. 
Each site had access to only their data. A patient status page 
showed investigators and assessors which outcomes to col-
lect at each time point; it included direct links to the relevant 
data entry form, which made the database simple to navi-
gate. Alternately, forms could be selected from a drop-down 
menu.
Statistical Design
SIRROWS, which we considered to be a phase 2 RCT, 
had a 2-group, randomized, repeated measures design with 
treatment blinding. Given the minimal risk to participants, 
we did not engage an external data monitoring and safety 
committee. The primary end point was walking speed at 
discharge. The reinforcement received by the experimental 
DRS group and the greater awareness about walking speed 
over time on the part of the therapist were anticipated to 
improve walking speed by 25% or by at least 0.2 m/s over 
the control NRS group. This gain would be at the upper level 
of differences found in prior trials that aimed to increase 
walking speed at various intervals after stroke (see Dis-
cussion). For an anticipated effect size of 0.4, a 2-tailed a 
of .01, and power of 0.9, we anticipated needing a sample 
size of 150 participants in each group, as long as drop-
outs were no more than 15%. We planned a futility analysis 
when about 50 participants from each arm of the trial had 
discharge data.
An analysis of covariance was planned for walking 
speed, LOS, and walking distance carried out by the general 
linear model and by Huber’s robust analysis of covariance 
if outliers were present. Additional interaction terms to be 
introduced included time from onset of stroke to entry and 
the initial NIHSS. In addition, the admission mRS and FAC 
were divided into a binary result and assessed by Fisher’s 
exact test. The mRS was divided into ≤2 (slight to no dis-
ability) versus ≥3 (moderate to severe disability). The FAC 
was divided into ≥4 (independent on level surfaces or better) 
versus <4 (0 = unable to walk; 1 and 2 = needs physical 
assistance; 3 = walks with supervision). Baseline descriptor 
data were compared by t tests.
Results
Eighteen sites enrolled 179 eligible patients between July 
2007 and February 2009 (Figure 1). About 10% of par-
ticipants in each group dropped out prior to the primary 
outcome assessment. Sites gradually came online. For exam-
ple, by November 2007, 25 sites had IRB approval, 13 had 
randomized participants, and 62 participants were enrolled. 
By April 2008, 17 sites had randomized 103 participants. 
We did not ask investigators to ascertain the number of 
participants who were screened at admission for inpatient 
rehabilitation, did not meet entry criteria, or refused to 
participate because this information would have required a 
part-time coordinator at each site for complete ascertain-
ment. We anticipated that about 15% of all admissions would 
be eligible. No adverse events or safety concerns related to 
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the daily walking task were reported on the database form. 
The planned interim analysis for walking speed was carried 
out by the study statistician without unblinding the RCT 
and determined that no more than 75 participants would be 
needed in each arm to show a difference, if one existed. We 
looked for significant differences in the results of walking 
speed before the interim analysis, which corresponded to 
the time we had to switch from immediate computer ran-
domization to e-mailing the result, and after the analysis, 
suggesting that this change in the randomization procedure 
did not lead to any systematic bias.
Descriptive Analysis
Ischemic stroke accounted for 81% of admissions, and 51% 
of strokes affected the left hemisphere. Baseline character-
istics are shown in Table 1. No significant differences were 
found between the 2 groups in terms of mean age, gender 
(59% males), time poststroke, stroke severity (NIHSS), ini-
tial walking speed, and proportion of people with mRS ≤ 2 
and FAC ≥ 4. On average, the initial self-selected fast walk-
ing speed was 0.45 m/s; 68% of all participants walked at 
less than 0.5 m/s at study entry. The proportion of patients 
who walked slower than 0.5 m/s was not significantly differ-
ent between the 2 groups. Overall, 76% were non-Hispanic 
Caucasians, 7% African or African American, 14% Asian, 
and 3% Hispanic.
Entered into database
(n = 216)
Ineligible entry or accidental/ 
duplicate entry 
(n = 37)
Eligible participants 
randomized
(n = 179)
Screened for eligibility
(data not collected; see text)
Allocated to DRS
(n = 88)
Allocated to NRS
(n = 91)
Lost to follow-up
(n = 7)
Analyzed for primary 
outcome
(n = 78)
Analyzed for primary 
outcome
(n = 84)
Lost to follow-up
(n = 10)
Figure 1. CONSORT diagram of flow of participants through the randomized controlled trial
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials; DRS, daily reinforcement of walking speed; NRS, no reinforcement  
of walking speed.
Table 1. Baseline Summary of SIRROWS Participants
 DRS,  NRS,  P
 Mean (SD) Mean (SD) Value
Number of participants 88 91 .91
Age (years) 62.9 (12.6) 65.1 (11.9) .85
Stroke onset to entry (days) 27.3 (78) 30.2 (53.5) .78
Initial walking speed (m/s) 0.45 (0.37) 0.46 (0.34) .98
NIHSS 6.4 (3.5) 6.6 (3.1) .74
mRS (≥2) 99% 97% .62
FAC (≥4) 4.9% 4.8% 1.00
Abbreviations: SIRROWS, Stroke Inpatient Rehabilitation With Reinforce-
ment of Walking Speed; SD, standard deviation; DRS, daily reinforcement 
of walking speed; NRS, no reinforcement of walking speed; NIHSS,  
National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; 
FAC, Functional Ambulation Classification.
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Primary Analysis
Table 2 shows the outcomes for the experimental DRS and 
the control NRS groups at discharge. Box plots strongly 
suggested that the walking speed data were skewed, so 
the data were transformed as log(speed at discharge + 0.5), 
which reduced the skewness to a negligible amount. For 
statistical modeling, we used this transformation and the 
covariates of treatment group, age, site, and time from stroke 
onset to study entry. The results were unchanged when 
carried out by the general linear model and by Huber’s 
robust analysis of covariance. Additional interaction terms—
admission NIHSS, mRS, and FAC—did not alter the results. 
With the transformed model, a standard residual analysis 
did not show any large deviations. We did not make adjust-
ments for missing data (about 10% of participants in each 
group) for walking velocity because SIRROWS was a 
phase 2 trial and the missing data appeared to have occurred 
randomly, unrelated to the interventions.
Both groups significantly increased their gait speed at 
discharge relative to baseline. However, the change in gait 
speed was greater for the DRS group in the primary analysis 
(P = .01). The mean change scores from baseline (DRS = 
0.45, standard deviation [SD] = 0.35; NRS = 0.27, SD = 
0.29) also significantly favored the DRS group (P = .01) at 
discharge. The difference between groups was retained at 
3 months postdischarge (P = .03), although the number of 
participants with data was reduced by 50% (DRS = 35; 
NRS = 48). By 6 months, only 35% of participants had 
velocity data.
Secondary Analyses
Unadjusted group means are given in Table 2 for walking 
distance and LOS. Walking distance in 3 minutes showed 
somewhat larger gains for the DRS group, but P = .09. The 
proportion of DRS compared with NRS participants who 
were independent ambulators was also at this near thresh-
old for significance. Feedback had no measurable effect 
on LOS. LOS, however, was greater (P < .0001) for the 
non-US sites, at 55.7 days (SD = 32.2), versus US sites, at 
19.4 days (SD = 11.0), which may have limited the utility of 
this parameter. Of note, analysis revealed that LOS was 
highly associated with the initial walking speed of partici-
pants in both groups; patients who walked <0.5 m/s at baseline 
had a longer LOS (P = .02). We examined for a baseline 
walking speed that might predict the LOS. Based on a tree 
structure classification analysis (CART), the most robust 
difference in each group occurred at 0.42 m/s, which would 
suggest, as anticipated, that greater locomotor disability 
may be the primary factor for a longer LOS.
Discussion
SIRROWS is the first international MRCT to test an interven-
tion to improve walking speed during inpatient rehabilitation 
for stroke. The results of the trial are novel. A single daily 
bout of feedback about performance for that day’s walking 
speed over a short distance led to significantly faster speeds 
at discharge compared with well-matched participants who 
did not receive feedback. Indeed, the velocity attained by 
the experimental group gave the average participant the 
ability to walk at a pace that is associated with the capacity 
for unlimited slow community mobility.1
The increase in walking speed from baseline in SIR-
ROWS was considerably better for both groups than prior 
RCTs of walking interventions, although prior studies usually 
started after inpatient rehabilitation had been completed.1,17 
The mean change scores from baseline to discharge were 
0.25 m/s for the NRS and 0.46 m/s for the DRS group. 
The DRS group doubled its speed between entry and dis-
charge. The difference in favor of DRS at discharge was 
0.19 m/s, which exceeds the minimal clinically important 
difference of >0.16 m/s, at least for comfortable walking 
speed in patients who had a similar initial speed within the 
early time frame of the SIRROWS trial.18
Other studies help put the DRS mean change and final 
walking velocity into general perspective. A Cochrane ana-
lysis of RCTs of overground training for patients whose 
time since stroke onset was longer than in SIRROWS 
revealed increases in walking speed resulting from the 
experimental treatment of up to 0.1 m/s.17 These gains are 
Table 2. Outcome Data at Discharge From Inpatient Rehabilitation
 DRS, Mean (SD), 95% CI  NRS, Mean (SD), 95% CI P Value
Walking speed (m/s) 0.91 (0.57), -0.21, 2.03 0.72 (0.44), -0.14, 1.58 .01
Length of rehabilitation  42.8 (34.7)  40.4 (28.7) .62 
stay (days)
Walking distance (m) 131.9 (75.4) 112.2 (61.0) .09
FAC ≥ 4 36% 24% .12
Abbreviations: SD, standard deviation; DRS, daily reinforcement of walking speed; NRS, no reinforcement of walking speed; CI, confidence interval;  
FAC, Functional Ambulation Classification.
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considerably smaller than those achieved by the DRS over 
the NRS arm of SIRROWS. A few studies included onset of 
gait training within the SIRROWS time frame of inpatient 
rehabilitation. One of the SIRROWS sites, for example, 
previously reported mean increases in walking speed in 226 
nonambulators, on admission for stroke rehabilitation, of 
0.19 m/s and a gain of 0.28 m/s in 147 patients who initially 
walked at 0.41 m/s.19 A recent 3-arm, phase 2 RCT exam-
ined different intensities of physical therapy for inpatients 
at a mean of 35 days poststroke.20 Half of the patients were 
not yet able to walk to obtain a baseline walking speed, and 
the other half had a mean velocity of 0.2 m/s. Mean veloci-
ties improved to 0.30 m/s in the arm that received the usual 
amount of therapy and to 0.55 m/s in the group with 15 h of 
additional therapy for 6 weeks. Results improved up to 
0.1 m/s across the groups after an additional 6 weeks of 
usual or more intensive treatment. Thus, most participants 
did not achieve community-level walking speeds. Another 
RCT probably included a more homogeneous and possibly 
more impaired group of patients than SIRROWS during 
acute stroke rehabilitation.21 Walking speed after 6 weeks 
increased from that at entry, when patients could not walk, 
to 0.40 m/s for a group randomized to receive extra lower-
extremity training, and to 0.20 m/s for the control groups. 
Mean speeds increased to 0.58 and 0.46 m/s at 12 weeks, 
respectively, with further increases to 0.65 and 0.55 m/s at 
20 weeks, which was at the end of the interventions. Thus, 
the mean walking speeds achieved in this sample were sim-
ilar to that of the NRS group but lower than that of the DRS 
group over a similar time frame.
The size of the effect in SIRROWS was also greater than 
velocity increases obtained with more complex interven-
tions, such as robotic assists. For example, a Cochrane review 
of RCTs through 2007 found that mean walking velocity 
increased only 0.08 m/s for robotic-trained participants.22 A 
subsequent RCT compared the Lokomat to overground 
training in slow walkers (0.34 m/s at onset) starting about 3 
to 4 months after onset of stroke. Velocity increased in the 
robotic group by only 0.06 m/s and in the conventional 
group by 0.18 m/s at the end of 24 sessions of therapy.5
The remarkably fast mean velocities achieved by the DRS 
group in SIRROWS cannot be compared with high confi-
dence to any of these trials, however, because of differences 
in the population sampled, the types and intensities of inter-
ventions, entry criteria, and time from onset of stroke to the 
start of rehabilitation. The modest improvements after prior 
attempts to improve walking speed in comparison to the 
SIRROWS result, however, suggest that even modest feed-
back and reinforcement about daily walking speed alone 
offers a conceptually sound, practical, low-technology, and 
no-cost intervention to potentially improve walking speed 
and related functional outcomes. If confirmed by additional 
studies, similar feedback should be included in the control 
and experimental arms of trials that deploy more costly and 
technologically complex walking interventions.23
Defining the type, timing, and frequency of feedback 
about the results of motor performance after stroke or other 
neurological diseases is a work in progress. For example, 
Boysen et al24 examined the effects of repeated encourage-
ment and verbal instructions about physical activity given 
at discharge from inpatient rehabilitation and at 3-month 
intervals for 12 months, then every 6 months, compared with 
a control group that received information about the possible 
benefits of being physically active but did not receive spe-
cific instruction. No significant increase in physical activity 
was found in these patients with mild impairments. Perhaps, 
the verbal encouragement was not frequent enough to produce 
sufficient motivation to change behavior. SIRROWS used 
daily verbal reinforcement on a more targeted behavior—
walking speed—with a more captive research group during 
inpatient rehabilitation. The frequency and specificity of 
feedback may be critical for success.
The secondary outcomes of SIRROWS were less respon-
sive to feedback. LOS was longer for most non-US sites. 
Thus, the potential confounder of wide variances in LOS 
among sites may have lessened the likelihood of finding a 
shorter LOS in the DRS group. By controlling for time from 
onset of stroke to entry and for LOS, however, this discrep-
ancy did not alter the significant results for walking speed. 
Also, secondary outcomes for walking distance and the 
proportion of DRS patients who were rated as independent 
ambulators did not reveal a statistically significant difference. 
With P values in the range of 0.1 within a phase 2 discovery 
trial, one should probably not reject an intervention or a 
measurement from further study, especially when the 
primary outcome suggests efficacy. Walking speed and dis-
tance often, in a laboratory setting, increase in unison after 
stroke, because patients use similar walking speeds for both 
tests.25 The FAC also usually improves in parallel with faster 
speeds, but once patients are independent walkers, speed 
may decrease.18
The results of SIRROWS need to be confirmed by a more 
rigorous RCT because we designed this trial as a stage 3 
intervention23 within the context of a phase 2 study. We had 
to plan the design in ways that were less optimal than other 
recent large trials for walking-related outcomes3,4 because 
we lacked financial resources to optimally manage SIRROWS 
and engaged rehabilitation sites that varied in experience 
and infrastructure. We aimed to make the instructions, data 
acquisition, and management so easy that the trial could be 
completed with integrity with only an electronic Internet-
based data entry strategy and within the usual daily therapy 
plans of centers. We could not anticipate being able to increase 
the complexity of feedback, define the type or amount of 
daily physical therapy, or collect neuroimaging studies, qual-
ity of life scales, and other data that could be confounded by 
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language and cultural differences. We also could not count 
on all sites to obtain outpatient measurements beyond the 
day of discharge, given likely differences in convenience of 
accessibility. Indeed, we encountered a sharp drop in col-
lected data after discharge.
Web-based, neurorehabilitation MRCTs with spare pro-
tocols can include sites from any place in the world, enabling 
a large number of investigators to contribute to the develop-
ment of everyday, evidence-based practices despite living in 
different health care cultures. This opportunity can increase 
the number of patients available to trials, enrich the daily 
practices of participating clinicians, and increase the ability 
to generalize the results of studies across populations. If col-
laborative networks like SIRROWS can enter large numbers 
of participants over relatively short periods, they can also 
test promising therapies for common and uncommon impair-
ments and disabilities, develop dose–response curves prior 
to a phase 3 RCT, and use more sophisticated interventions 
and outcome measurements that are culturally relevant.26,27
Conclusion
Immediate reinforcement about daily walking speed during 
inpatient stroke rehabilitation may lead to clinically signifi-
cant gains in walking speed. Further trials by a network of 
collaborating sites can build on the SIRROWS results by 
examining greater frequency of feedback during inpatient 
care and add feedback during the first 3 to 6 months of out-
patient rehabilitation to determine the optimal dose of this 
strategy as well as examine longer-term outcomes.
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